Publications by authors named "Tomas Seidal"

Claim this Profile
T
The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks.
Mohammed S I Mansour, Louise Pettersson, Tomas Seidal, Ulf Strömberg, Ulrich Mager

Cancer Cytopathol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
Mohammed S I Mansour, Adela Huseinzade, Tomas Seidal, Kim Hejny, Athar Maty

Cytopathology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines.
Kajsa Ericson Lindquist, Cristina Ciornei, Sofia Westbom-Fremer, Inga Gudinaviciene, Anna Ehinger, Tomas Seidal

J Clin Pathol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations.
Mohammed S I Mansour, Karina Malmros, Ulrich Mager, Kajsa Ericson Lindquist, Kim Hejny, Tomas Seidal

Int J Mol Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature.
Mohammed S I Mansour, Kajsa Ericson Lindquist, Tomas Seidal, Ulrich Mager, Rikard Mohlin

Acta Cytol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer.
Mohammed S I Mansour, Kim Hejny, Felicia Johansson, Joudy Mufti, Ante Vidis, Tomas Seidal

Diagnostics (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma.
Mohammed S I Mansour, Tomas Seidal, Ulrich Mager, Katalin Dobra, Hans Brunnström

Cancer Cytopathol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-II.
Ingiridur Skirnisdottir, Helena Akerud, Tomas Seidal, Inger Sundstrom-Poromaa

Cancer Genomics Proteomics· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II.
Ingiridur Skirnisdottir, Helena Åkerud, Tomas Seidal

Int J Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of PD-L1 expression in effusions from mesothelioma by immuno-cytochemical staining.
Mohammed S I Mansour, Tomas Seidal, Ulrich Mager, Amir Baigi, Katalin Dobra

Cancer Cytopathol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer.
Kathrine Bjersand, Tomas Seidal, Inger Sundström-Poromaa, Helena Åkerud, Ingiridur Skirnisdottir

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The debate about the very late abortions is much needed].
Tomas Seidal, Andrea Kischkel

Lakartidningen· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.
Ingiridur Skirnisdottir, Tomas Seidal, Helena Åkerud

Int J Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages of M1 phenotype have properties that influence lung cancer cell progression.
Alexander Hedbrant, Jonny Wijkander, Tomas Seidal, Dick Delbro, Ann Erlandsson

Tumour Biol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.
Ingiridur Skirnisdottir, Tomas Seidal, Helena Åkerud

Int J Gynecol Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Napsin A as a marker of clear cell ovarian carcinoma.
Ingiridur Skirnisdottir, Kathrine Bjersand, Helena Akerud, Tomas Seidal

BMC Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
Ingiridur Skirnisdottir, Tomas Seidal

Cancer Genomics Proteomics· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
Ingirídur Skírnisdóttir, Tomas Seidal

Int J Gynecol Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice.
Ann Erlandsson, Eva Forssell-Aronsson, Tomas Seidal, Peter Bernhardt

EJNMMI Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer.
Ingirídur Anna Skírnisdóttir, Bengt Sorbe, Katarina Lindborg, Tomas Seidal

Int J Gynecol Cancer· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The Medical Association should give guidance on members' freedom of conscience right].
Christina Doctare, Bengt Malmgren, Tomas Seidal

Lakartidningen· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy.
Dragomir P Zubac, Tore Wentzel-Larsen, Tomas Seidal, Leif Bostad

BMC Urol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Dragomir P Zubac, Leif Bostad, Björn Kihl, Tomas Seidal, Tore Wentzel-Larsen

J Urol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Premature infants' right to cae and the unwillingness to modify the view on abortions].
Tomas Seidal

Lakartidningen· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy.
Dragomir P Zubac, Leif Bostad, Tomas Seidal, Tore Wentzel-Larsen, Svein A Haukaas

BMC Urol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis